AllianceBernstein’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.59M | Hold |
113,360
| – | – | ﹤0.01% | 2049 |
|
|
2025
Q1 | $1.77M | Buy |
113,360
+2,200
| +2% | +$34.4K | ﹤0.01% | 1971 |
|
|
2024
Q4 | $1.55M | Hold |
111,160
| – | – | ﹤0.01% | 2100 |
|
|
2024
Q3 | $1.03M | Hold |
111,160
| – | – | ﹤0.01% | 2312 |
|
|
2024
Q2 | $1.03M | Buy |
111,160
+36,460
| +49% | +$339K | ﹤0.01% | 2284 |
|
|
2024
Q1 | $740K | Buy |
74,700
+7,440
| +11% | +$73.7K | ﹤0.01% | 2413 |
|
|
2023
Q4 | $217K | Sell |
67,260
-5,100
| -7% | -$16.5K | ﹤0.01% | 2955 |
|
|
2023
Q3 | $384K | Sell |
72,360
-7,670
| -10% | -$40.7K | ﹤0.01% | 2701 |
|
|
2023
Q2 | $763K | Sell |
80,030
-68,470
| -46% | -$653K | ﹤0.01% | 2424 |
|
|
2023
Q1 | $1.63M | Buy |
148,500
+110,000
| +286% | +$1.21M | ﹤0.01% | 1991 |
|
|
2022
Q4 | $570K | Buy |
38,500
+10,200
| +36% | +$151K | ﹤0.01% | 2559 |
|
|
2022
Q3 | $541K | Hold |
28,300
| – | – | ﹤0.01% | 2604 |
|
|
2022
Q2 | $603K | Buy |
28,300
+8,000
| +39% | +$170K | ﹤0.01% | 2594 |
|
|
2022
Q1 | $391K | Hold |
20,300
| – | – | ﹤0.01% | 2762 |
|
|
2021
Q4 | $421K | Buy |
20,300
+1,500
| +8% | +$31.1K | ﹤0.01% | 2800 |
|
|
2021
Q3 | $449K | Hold |
18,800
| – | – | ﹤0.01% | 2787 |
|
|
2021
Q2 | $513K | Buy |
18,800
+5,100
| +37% | +$139K | ﹤0.01% | 2786 |
|
|
2021
Q1 | $396K | Sell |
13,700
-2,100
| -13% | -$60.7K | ﹤0.01% | 2762 |
|
|
2020
Q4 | $444K | Sell |
15,800
-59,864
| -79% | -$1.68M | ﹤0.01% | 2638 |
|
|
2020
Q3 | $2.22M | Sell |
75,664
-1,700
| -2% | -$49.8K | ﹤0.01% | 1789 |
|
|
2020
Q2 | $2.34M | Buy |
77,364
+8,528
| +12% | +$258K | ﹤0.01% | 1746 |
|
|
2020
Q1 | $2.05M | Buy |
+68,836
| New | +$2.05M | ﹤0.01% | 1649 |
|